Botulinum toxin type E associated with reduced itch and pain during wound healing and acute scar formation following excision and linear repair on the forehead: A randomized controlled trial - 11/11/23
Doi : 10.1016/j.jaad.2023.08.072
Murad Alam, MD, MSCI, MBA a, b, c, d, ⁎ 
, Domenico Vitarella, PhD e, Wajdie Ahmad, MBA e, Susan Abushakra, MD e, Cheri Mao, MSc f, †, Mitchell F. Brin, MD f, g
, Domenico Vitarella, PhD e, Wajdie Ahmad, MBA e, Susan Abushakra, MD e, Cheri Mao, MSc f, †, Mitchell F. Brin, MD f, g a Department of Dermatology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
b Department of Otolaryngology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
c Department of Surgery, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
d Department of Medical Social Sciences, Feinberg School of Medicine, Northwestern University, Chicago, Illinois
e Bonti, Inc, AbbVie Company, Newport Beach, California
f AbbVie, Irvine, California
g University of California, Irvine, California
∗Correspondence to: Murad Alam, MD, MSCI, MBA, Department of Dermatology, Feinberg School of Medicine, Northwestern University, 676 N St. Clair St, Suite 1600, Chicago, IL 60611Department of DermatologyFeinberg School of MedicineNorthwestern University676 N St. Clair StSuite 1600ChicagoIL60611
Key words : botulinum toxin, cutaneous surgery, pain, scar, wound healing
Plan
| Funding sources: This study was supported by Bonti, Inc (prior to its acquisition by AbbVie). Writing assistance and editorial support was provided by Erika von Grote, PhD, a former employee of AbbVie, and Adrienne Drinkwater, PhD of Peloton Advantage, LLC, an OPEN Health company, and was funded by AbbVie. Neither honoraria nor other form of payment was made for authorship. |
|
| IRB approval status: This study was approved by Northwestern University's Institutional Review Board (STU00206522) and registered on clinicaltrials.gov (NCT03346902). |
|
| Patient consent: Not applicable. |
© 2023
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 89 - N° 6
P. 1317-1319 - décembre 2023 Retour au numéro
Article précédent
- Nail disorders in skin of color: A retrospective chart review over a 5-year period
- Caralin Schneider, Natalie M. Williams, Brian W. Morrison, Antonella Tosti
- Implications of the Supreme Court’s affirmative action decision on underrepresented populations and dermatology
- Nicole Trepanowski, Jane M. Grant-Kels
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?